TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/05 21:29 | 6/6/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S | -2,184 | 7.57 | 0 | -289 | -12 | 2,208 | I | ||||||||||||||||
6/7/05 21:28 | 6/3/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S | -798 | 7.98 | 0 | -100 | -4 | 2,497 | I | ||||||||||||||||
6/7/05 21:28 | 6/2/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S.a | -432 | 8.57 | 0 | -50 | -2 | 2,597 | I | ||||||||||||||||
6/7/05 21:27 | 6/2/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S.a | -605 | 8.26 | 0 | -73 | -3 | 2,647 | I | ||||||||||||||||
6/6/05 14:43 | 6/2/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S | -432 | 8.57 | 0 | -50 | -2 | 2,587 | I | ||||||||||||||||
6/6/05 14:40 | 6/2/05 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Hbm Bioventures AG | V8 | T | S | -605 | 8.26 | 0 | -73 | -3 | 2,637 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |